Pfizer Inc. + BioNTech SE announced that the first participants have been dosed in a global phase II/III study to evaluate the Pfizer-BioNTech COVID-19 vaccine in preventing COVID-19 in pregnant women 18 years of age and older .
Why sign up with Medthority?
Develop your knowledge with our disease and condition focused Learning Zones
Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines
Personalised dashboard providing updates and recommendations for content within your areas of interest